By any economic measure, the Food and Drug Administration (FDA) is one of the most important regulatory bodies in the federal ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how ...

The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) today announced the ...

The FDA and EMA have aligned on ten guiding principles for the responsible use of artificial intelligence across the drug development lifecycle, establishing a shared framework to support innovation, ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

The UK pharmaceutical giant AstraZeneca is doubling down on its commitment to the Chinese drugmaker CSPC Pharmaceutical Group ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...

Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...